10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Salmeterol Xinafoate (CAS RN 94749-08-3), imported in bulk form, from India
Issued June 20, 2001 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardH8 H82428 (June 20, 2001)
Tariff classification
HTS codes: 2922.50.2500
Headings: 2922
Product description
The subject product, Salmeterol Xinafoate, is a bronchodilator drug used in the treatment of asthma.
CBP rationale
The applicable subheading for Salmeterol Xinafoate, imported in bulk form, will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTS), which provides for "Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: Aromatic: Other: Drugs: Other: Other.
Full text
NY H82428 June 20, 2001 CLA-2-29:RR:NC:2:238 H82428 CATEGORY: Classification TARIFF NO.: 2922.50.2500 Mr. Michael R. Tartaro Byron Chemical Company, Inc. 40-11 23rd Street Long Island City, NY 11101 RE: The tariff classification of Salmeterol Xinafoate (CAS RN 94749-08-3), imported in bulk form, from India Dear Mr. Tartaro: In your letter dated May 31, 2001, you requested a tariff classification ruling. The subject product, Salmeterol Xinafoate, is a bronchodilator drug used in the treatment of asthma. The applicable subheading for Salmeterol Xinafoate, imported in bulk form, will be 2922.50.2500, Harmonized Tariff Schedule of the United States (HTS), which provides for "Oxygen-function amino-compounds: Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: Aromatic: Other: Drugs: Other: Other." Pursuant to General Note 13, HTS, the rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Vilanterol Trifenatate (CAS No. 503070-58-4) in bulk powder form and Umeclidinium Bromide (CAS No. 869113-09-7) in bulk powder form, from India
The tariff classification of Salmeterol Xinafoate (CAS No. 94749-08-3) in bulk power form, from Spain
The tariff classification of Albuterol Sulfate (CAS No. 51022-70-9) in bulk powder form, from Italy
The tariff classification of Droxydopa (CAS 23651-95-8) in bulk powder form, from Italy
The tariff classification of Bromfenac Sodium (CAS-126038-55-3), imported in bulk powder form, from Italy
The tariff classification of Mesalamine (CAS-89-57-6) in bulk form, from Italy
The tariff classification of Nepafenac (CAS-78281-72-8); Posaconazole (CAS-171228-49-2) and Bromfenac Sodium (CAS-91714-93-1) in bulk powder form, from Italy
The tariff classification of Fesoterodine Fumarate (CAS-286930-03-8) in bulk form, from Spain
The tariff classification of Nomegesterol Acetate (CAS-58652-20-3) and Venlafaxine Hydrochloride (CAS-99300-78-4) in bulk form, from Italy and China, respectively
The tariff classification of Tramadol Hydrochloride (CAS-22204-88-2) in bulk form, from Italy
Follow H82428
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.